Broadcom Down Nearly 9%, on Pace for Largest Percent Decrease Since March 2020 — Data Talk
Broadcom Inc. (AVGO) is currently at $139.35, down $13.47 or 8.81%
--Would be lowest close since Aug. 7, 2024, when it closed at $136.27
--On pace for largest percent decrease since March 18, 2020, when it fell 15.86%
--Currently down three of the past four days
--Currently down two consecutive days; down 9.58% over this period
--Worst two day stretch since the two days ending Aug. 2, 2024, when it fell 10.49%
--Up 24.84% year-to-date
--Down 23.8% from its all-time closing high of $182.89 on June 17, 2024
--Up 62.5% from 52 weeks ago (Sept. 8, 2023), when it closed at $85.76
--Down 23.8% from its 52-week closing high of $182.89 on June 17, 2024
--Up 72.39% from its 52-week closing low of $80.84 on Sept. 21, 2023
--Traded as low as $137.62; lowest intraday level since Aug. 7, 2024, when it hit $135.83
--Down 9.95% at today's intraday low; largest intraday percent decrease since Aug. 5, 2024, when it fell as much as 10.65%
--Worst performer in the S&P 500 today
--Third most active stock in the S&P 500 today
--Worst performer in the Nasdaq 100 today
--Third most active stock in the Nasdaq 100 today
All data as of 9:47:43 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 06, 2024 10:05 ET (14:05 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk